Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Voglibose-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely voglibose 200 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely voglibose 200 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Voglibose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing voglibose in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Voglibose only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Voglibose 300 microgram oral tablet |
Has precise active ingredient |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Voglibose 300 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin- and voglibose-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metformin and voglibose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing metformin and voglibose in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin and voglibose only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin hydrochloride 500 mg and voglibose 200 microgram oral tablet |
Has precise active ingredient |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin hydrochloride 500 mg and voglibose 200 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Voglibose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |